Hearing Program in Primary Care

Sponsor
NYU Langone Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05943509
Collaborator
(none)
120
1
2
21.9
5.5

Study Details

Study Description

Brief Summary

During a primary care visit, investigators will screen and identify participants with hearing loss and then randomize to a) counseling on accessible assistive listening devices or b) referral to traditional audiology care pathway alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Alternative rehabilitation strategies
  • Behavioral: Usual Care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Feasibility of a Hearing Program in Primary Care for Underserved Older Adults
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2025
Anticipated Study Completion Date :
Jun 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alternative Rehabilitation Strategies

Patients who screened positive for hearing loss and were randomized into the counselling on alternative rehabilitation strategies intervention arm.

Behavioral: Alternative rehabilitation strategies
Counseling intervention.

Active Comparator: Usual Care

Patients who screened positive for hearing loss and were randomized into the usual care audiology pathway control arm alone.

Behavioral: Usual Care
Usual care audiology pathway.

Outcome Measures

Primary Outcome Measures

  1. Number of Potential Participants Approached [Up to Month 3]

  2. Number of Potential Participants Screened [Up to Month 3]

  3. Percentage of Screened Participants with Hearing Loss [Up to Month 3]

Secondary Outcome Measures

  1. Percentage of Intervention Arm Participants who Complete Counseling Session [Up to Month 3]

  2. Percentage of Participants who Respond to Outreach to Confirm Recommendations within 72 Hours [Up to Month 3]

  3. Percentage of Participants who Respond to 3-Month Follow-Up [Month 3]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • speaks English or Spanish;

  • capacity to consent to research

Exclusion Criteria:

• has or uses hearing aids or cochlear implants

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYC H+H/Bellevue New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: David Friedmann, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05943509
Other Study ID Numbers:
  • 23-00648
First Posted:
Jul 13, 2023
Last Update Posted:
Jul 13, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2023